Loading Video…
This browser does not support the Video element.
FDA grants emergency authorization for antibody therapy
The treatment will be used for high-risk patients with mild to moderate symptoms.
This browser does not support the Video element.
The treatment will be used for high-risk patients with mild to moderate symptoms.